Is Glaropharm AG FDA approved?

Glaropharm AG holds 1 FDA-registered establishment in Switzerland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Glaropharm AG's drugs manufactured?

The FDA register lists Mitl�di. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.

Glaropharm AG

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 0
Live patents: 0
Countries: 1
Base: Switzerland

Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Glaropharm AG	Saendli 2, Mitl�di, Glarus 8756, Switzerland (CHE)	Analytical testing, Labelling, Finished drug manufacture, Packaging	3009997166483257270

Compare

Comparable companies in Switzerland

Ricola Ag1 site · 84 NDC
Avyxa GmbH1 site · 29 NDC
Bachem AG1 site · 23 NDC
Vifor (International) AG1 site · 22 NDC
DOTTIKON EXCLUSIVE SYNTHESIS AG1 site · 16 NDC
HAS Healthcare Advanced Synthesis SA1 site · 11 NDC
Cerbios-Pharma SA1 site · 9 NDC
SINTETICA S.A.1 site · 9 NDC
Similasan AG1 site · 7 NDC
Swiss Caps AG1 site · 6 NDC

Enquiry

Common questions

Is Glaropharm AG FDA approved?: Glaropharm AG holds 1 FDA-registered establishment in Switzerland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Glaropharm AG's drugs manufactured?: The FDA register lists Mitl�di. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.